The potential relevance of some genes in IBD has been supported by previous studies, such as RETN with increased resistin levels in CD and primary sclerosing cholangitis,32,33 the FLT3 receptor in a mouse model of chronic ileitis,34 and the therapeutic potential of IL-18 inhibition.35 This evidence concerns the gene IL18 and sclerosing cholangitis.